TGFB1 and neoplasm: SMAD4, a transforming growth factor (TGF)-β/BMP signaling effector and a tumor suppressor, is frequently mutated in PDAC and actively participates in the interaction between cancer and stromal myeloid cells and mediates the response of cancer cells to stromal chemokine [67].